CA-125 and heart failure: Déjà vu or "still to be seen"

International Journal of Cardiology

Volumn 145, Issue 3, 2010, Pages 626-629

  Topatan, Betül ^a   Basaran, Ahmet ^b  

^a BASKENT UNIVERSITY   (Turkey)

^b Kulu State Hospital   (Turkey)

Author keywords

CA 125; Heart failure; Mesothelium

Indexed keywords

CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ACUTE HEART FAILURE; BLOOD LEVEL; CHRONIC DISEASE; DISEASE MARKER; HEART FAILURE; HUMAN; INFLAMMATION; LETTER; LUNG DISEASE; LUNG EDEMA; MESOTHELIUM CELL; OVARY CANCER; PERITONEUM CELL; PRIORITY JOURNAL; TUMOR CELL;

EID: 78649911069     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.09.060     Document Type: Article

References (42)

1. S. Monteiro, F. Franco, and S. Costa Prognostic value of CA125 in advanced heart failure patients Int J Cardiol 140 1 2010 Apr 1 115 118
2. G. Minana, J. Nunez, J. Sanchis, V. Bodi, E. Nunez, and A. Llacer CA125 and immunoinflammatory activity in acute heart failure Int J Cardiol 2010 May 17 Epub
3. M. Refiker, and M.B. Yilmaz Association of right heart with CA-125 levels in patients with heart failure Int J Cardiol 2010 May 12 Epub
4. R.C. Bast Jr., T.L. Klug, and E. St John A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer N Engl J Med 309 15 1983 Oct 13 883 887
5. C. Miralles, M. Orea, and P. Espana Cancer antigen 125 associated with multiple benign and malignant pathologies Ann Surg Oncol 10 2 2003 Mar 150 154
6. A.G. Zeimet, C. Marth, and F.A. Offner Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumour marker CA-125 Gynecol Oncol 62 3 1996 Sep 384 389
7. C. Whitehouse, and E. Solomon Current status of the molecular characterization of the ovarian cancer antigen CA125 and implications for its use in clinical screening Gynecol Oncol 88 1 Pt 2 2003 Jan S152 S157
8. M. Epiney, C. Bertossa, A. Weil, A. Campana, and P. Bischof CA125 production by the peritoneum: in-vitro and in-vivo studies Hum Reprod 15 6 2000 Jun 1261 1265
9. E. Zuckerman, A. Lanir, and E. Sabo Cancer antigen 125: a sensitive marker of ascites in patients with liver cirrhosis Am J Gastroenterol 94 6 1999 Jun 1613 1618
10. A.M. Zeillemaker, H.A. Verbrugh, A.A. Hoynck van Papendrecht, and P. Leguit CA 125 secretion by peritoneal mesothelial cells J Clin Pathol 47 3 1994 Mar 263 265
11. O.M. Hess, and J.D. Carroll Clinical assessment of heart failure E. Braunwald, BRAUNWALD'S Heart Disease: A Textbook of Cardiovascular Medicine 2007 562
12. A. D'Aloia, P. Faggiano, and G. Aurigemma Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and doppler echocardiographic abnormalities, and short-term prognosis J Am Coll Cardiol 41 10 2003 May 21 1805 1811
13. L. Soma, M. Allen, and L. Tobin CA-125 concentrations in patients awaiting cardiac transplantation Clin Chem 48 12 2002 Dec 2289 2290
14. J. Nunez, J. Sanchis, and V. Bodi Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure Eur Heart J 31 14 2010 Jul 1752 1763
15. T. Seo, Y. Ikeda, and H. Onaka Usefulness of serum CA125 measurement for monitoring pericardial effusion Jpn Circ J 57 6 1993 Jun 489 494
16. A. Basaran, and S. Zafer Tuncer Ascites is the primary cause of cancer antigen-125 (CA-125) elevation in systemic lupus erythematosus (SLE) patients with nephrotic syndrome Med Hypotheses 68 1 2007 197 201
17. A. Sevinc, S. Buyukberber, R. Sari, Y. Kiroglu, H.M. Turk, and M. Ates Elevated serum CA-125 levels in hemodialysis patients with peritoneal, pleural, or pericardial fluids Gynecol Oncol 77 2 2000 May 254 257
18. A. Oaknin, P. Barretina, and X. Perez CA-125 response patterns in patients with recurrent ovarian cancer treated with pegylated liposomal doxorubicin (PLD) Int J Gynecol Cancer 20 1 2010 Jan 87 91
19. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2 2009 Jan 9 149 150
20. Soma L., Allen M., Tobin L., Ganster C., Bulley M., and Hunt J. CA-125 concentrations in patients awaiting cardiac transplantation Clin Chem 48 12 2002 Dec 2289 2290
21. Nagele H., Bahlo M., Klapdor R., Schaeperkoetter D., and Rodiger W. CA 125 and its relation to cardiac function Am Heart J 137 6 1999 Jun 1044 1049
22. De Gennaro L., Brunetti ND., Bungaro R., Montrone D., Cuculo A., and Pellegrino P.L. Carbohydrate antigen-125: additional accuracy in identifying patients at risk of acute heart failure in acute coronary syndrome Coron Artery Dis 20 4 2009 Jun 274 280
23. Mansour I.N., Napan S., Tarek Alahdab M., and Stamos T.D. Carbohydrate antigen 125 predicts long-term mortality in African American patients with acute decompensated heart failure Congest Heart Fail 16 1 2010 Jan-Feb 15 20
24. Nunez J., Nunez E., Consuegra L., Sanchis J., Bodi V., and Martinez-Brotons A. Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure? Heart 93 6 2007 Jun 716 721
25. Kouris N.T., Kontogianni D.D., Papoulia E.P., Goranitou G.S., Zaharos I.D., and Grassos H.A. Clinical and prognostic value of elevated CA125 levels in patients with congestive heart failure Hellenic J Cardiol 47 5 2007 Jun 269 274
26. Varol E., Ozaydin M., Altinbas A., Aslan S.M., Dogan A., and Dede O. Elevated carbohydrate antigen 125 levels in hypertrophic cardiomyopathy patients with heart failure Heart Vessels 22 1 2007 Jan 30 33
27. Duman C., Ercan E., Tengiz I., Bozdemir H., Ercan HE., and Nalbantgil I. Elevated serum CA 125 levels in mitral stenotic patients with heart failure Cardiology 100 1 2003 7 10
28. Duman C., Ercan E., Tengiz I., Bozdemir H., Ercan HE., and Nalbantgil I. Nalbantgil I. Elevated serum CA 125 levels in mitral stenotic patients with heart failure Cardiology 100 1 2003 7 10
29. Mathew B., Bhatia V., Mahy I.R., Ahmed I., and Francis L. Elevation of the tumour marker CA125 in right heart failure South Med J 97 10 2004 1013 1014
30. Skorzynska H., Solski J., Gernand W., Matras P., Gniwek M., and Sokol M. Estimation of CA 125 concentration in patients with congestive heart failure Ann Univ Mariae Curie Sklodowska Med 59 1 2004 261 264
31. Antonini-Canterin F., Popescu B.A., Popescu A.C., Beladan C.C., Korcova R., and Piazza R. Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement Int J Cardiol 128 3 2008 Aug 29 406 412
32. Nunez J., Sanchis J., Bodi V., Fonarow G.C., Nunez E., and Bertomeu-Gonzalez V. Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure Eur Heart J 31 14 2010 Jul 1752 1763
33. Yilmaz M.B., Zorlu A., and Tandogan I. Plasma CA-125 level is related to both sides of the heart: A retrospective analysis Int J Cardiol 2009 Dec 18
34. Monteiro S., Franco F., Costa S., Monteiro P., Vieira H., and Coelho L. Prognostic value of CA125 in advanced heart failure patients Int J Cardiol 140 1 2010 Apr 1 115 118
35. Turk H.M., Pekdemir H., Buyukberber S., Sevinc A., Camci C., and Kocabas R. Serum CA 125 levels in patients with chronic heart failure and accompanying pleural fluid Tumour Biol 24 4 2003 Aug-Sep 172 175
36. Duman D., Palit F., Simsek E., and Bilgehan K. Serum carbohydrate antigen 125 levels in advanced heart failure: relation to B-type natriuretic peptide and left atrial volume Eur J Heart Fail 10 6 2008 Jun 556 559
37. D'Aloia A., Faggiano P., Aurigemma G., Bontempi L., Ruggeri G., and Metra M. Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis J Am Coll Cardiol 41 10 2003 May 21 1805 1811
38. Faggiano P., D'Aloia A., Brentana L., Bignotti T., Fiorina C., and Vizzardi E. Serum levels of different tumour markers in patients with chronic heart failure Eur J Heart Fail 7 1 2005 Jan 57 61
39. Kouris NT., Zacharos ID., Kontogianni D.D., Goranitou GS., Sifaki M.D., and Grassos H.E. The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters Eur J Heart Fail 7 2 2005 Mar 2 199 203
40. Varol E., Ozaydin M., Dogan A., and Kosar F. Tumour marker levels in patients with chronic heart failure Eur J Heart Fail 7 5 2005 Aug 840 843
41. Seo T., Ikeda Y., Onaka H., Hayashi T., Kawaguchi K., and Kotake C. Usefulness of serum CA125 measurement for monitoring pericardial effusion Jpn Circ J 57 6 1993 Jun 489 494
42. Chen Y.X., Wang X.Q., Fang C.F., Wang J.F., and Tang L.J. Value of BNP and tumour marker CA125 in patients with heart failure Acta Cardiol 63 4 2008 Aug 501 506